Farms.com Home   News

You Got to Know When to Hold ‘Em

Deciding when to sell a crop is a difficult decision. Producers can sell prior to harvest, at harvest in the fall, or store the crop and sell after the first of the year. There are advantages and disadvantages to each. Many producers wait to market their crop until after the calendar turns. Figures from the Nebraska Corn Board indicate 57 percent of corn harvested in Nebraska is marketed after January 1. Joe Janzen, an agricultural economist with the University of Illinois, says 60 percent of corn and soybeans produced in Illinois remains to be sold at the end of a year.

Janzen explores the pros and cons of holding and selling grain after the first of the year in his paper, Post-harvest Grain Marketing: Do Farmers Reap the Benefits? Farmers’ primary motive for holding grain is better prices. Commodity prices typically rise between January through June and producers hope to capture this gain. Figure 1, from Janzen’s paper, shows the seasonal price variation in cash prices for corn and soybeans in Illinois for crop marketing years 2003-2020.

Figure 1. Price Variation in Central Illinois, Deviation From Marketing Year Average

crop

Using farm-specific data from the Illinois Farm Business Farm Management Association, Janzen examines the marketing performances of farms who sell corn both prior to January 1 and after January 1. By comparing the prices realized during both periods, a comparison of marketing performance can be made. Janzen was able to gather around 16,000 farm-year marketing observations between 2003-2020 for the analysis.

Click here to see more...

Trending Video

Finding a Balance of Innovation and Regulation - Dr. Peter Facchini

Video: Finding a Balance of Innovation and Regulation - Dr. Peter Facchini

Regulations help markets and industry exist on level playing fields, keeping consumers safe and innovation from going too far. However, incredibly strict regulations can stunt innovation and cause entire industries to wither away. Dr. Peter James Facchini brings his perspective on how existing regulations have slowed the advancement of medical developments within Canada. Given the international concern of opium poppy’s illicit potential, Health Canada must abide by this global policy. But with modern technology pushing the development of many pharmaceuticals to being grown via fermentation, is it time to reconsider the rules?

Dr. Peter James Facchini leads research into the metabolic biochemistry in opium poppy at the University of Calgary. For more than 30 years, his work has contributed to the increased availability of benzylisoquinoline alkaloid biosynthetic genes to assist in the creation of morphine for pharmaceutical use. Dr. Facchini completed his B.Sc. and Ph.D. in Biological Sciences at the University of Toronto before completing Postdoctoral Fellowships in Biochemistry at the University of Kentucky in 1992 & Université de Montréal in 1995.